Literature DB >> 8903384

Azygos blood flow: phase contrast quantitation in volunteers and patients with portal hypertension pre- and postintrahepatic shunt placement.

J F Debatin1, B Zahner, C Meyenberger, B Romanowski, W Schöpke, B Marincek, W A Fuchs.   

Abstract

Flow volume in the azygos venous system was quantitated with Cine-phase contrast (PC) velocity mapping in volunteers and compared with patients with known portal hypertension, who were referred for transjugular intrahepatic portosystemic shunt (TIPS) placement. Subsequently, the TIPS-induced hemodynamic effects on portal and azygos flow were analyzed. To assess intra- and intersubject variability, flow in the azygos veins was measured in each of 10 normal subjects at three different times. Subsequently, portal and azygos flow was quantitated in 20 patients with portal hypertension, before and after TIPS placement. All imaging was performed on a 1.5-tesla magnetic resonance imaging (MRI) system. Azygos flow was measured transaxially at the midthoracic level. Cine-PC flow measurements of the main portal vein followed morphological evaluation of the portal venous system with axial and coronal breath-held magnet resonance angiogram. Azygos flow in normal subjects was characterized by high inter- and low intrasubject variability. Azygos flow in patients with portal hypertension was significantly higher (P < .001). Following successful TIPS placement in 18 patients, Cine-PC revealed a mean decrease in azygos flow of 46.3% (P < .001) and a 134% (P < .001) increase of portal flow. Reflecting the complexity of portal hemodynamics, there was no correlation between the changes in the portal and azygos systems. In 2 patients with early occlusion of TIPS, documented invasively, portal and azygos flow values remained largely unchanged. Cine-PC enables the noninvasive, quantitative assessment of flow within the azygos venous system. Azygos flow was found to be markedly elevated in patients with portal hypertension. Combined portal and azygos PC flow measurements quantitate the therapeutic effect of TIPS placement.

Entities:  

Mesh:

Year:  1996        PMID: 8903384     DOI: 10.1002/hep.510240522

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  5 in total

1.  Portal hypertension in patients with cirrhosis: indirect assessment of hepatic venous pressure gradient by measuring azygos flow with 2D-cine phase-contrast magnetic resonance imaging.

Authors:  Hervé Gouya; Sophie Grabar; Olivier Vignaux; Anastasia Saade; Stanislas Pol; Paul Legmann; Philippe Sogni
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

2.  Four-dimensional Flow MRI as a Marker for Risk Stratification of Gastroesophageal Varices in Patients with Liver Cirrhosis.

Authors:  Utaroh Motosugi; Alejandro Roldán-Alzate; Peter Bannas; Adnan Said; Sean Kelly; Ryan Zea; Oliver Wieben; Scott B Reeder
Journal:  Radiology       Date:  2018-10-16       Impact factor: 11.105

3.  Reversible decrease of portal venous flow in cirrhotic patients: a positive side effect of sorafenib.

Authors:  Romain Coriat; Hervé Gouya; Olivier Mir; Stanislas Ropert; Olivier Vignaux; Stanislas Chaussade; Philippe Sogni; Stanislas Pol; Benoit Blanchet; Paul Legmann; François Goldwasser
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240

4.  Vascular assessment of liver disease-towards a new frontier in MRI.

Authors:  Manil D Chouhan; Mark F Lythgoe; Rajeshwar P Mookerjee; Stuart A Taylor
Journal:  Br J Radiol       Date:  2016-05-16       Impact factor: 3.039

5.  Evaluation of Doppler-ultrasonography in the diagnosis of transjugular intrahepatic portosystemic shunt dysfunction: A prospective study.

Authors:  Charlotte Nicolas; Amélie Le Gouge; Louis d'Alteroche; Jean Ayoub; Monica Georgescu; Vincent Vidal; Denis Castaing; Jean-Pierre Cercueil; Patrick Chevallier; Jérôme Roumy; Hervé Trillaud; Louis Boyer; Vincent Le Pennec; Christophe Perret; Bruno Giraudeau; Jean-Marc Perarnau
Journal:  World J Hepatol       Date:  2017-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.